Marshall Wace’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.1K Buy
+30,400
New +$64.1K ﹤0.01% 2430
2024
Q4
Sell
-52,259
Closed -$144K 2531
2024
Q3
$144K Buy
52,259
+33,434
+178% +$91.9K ﹤0.01% 2163
2024
Q2
$42.5K Buy
+18,825
New +$42.5K ﹤0.01% 2231
2021
Q3
Sell
-47,509
Closed -$152K 2546
2021
Q2
$152K Buy
+47,509
New +$152K ﹤0.01% 1980